[1]
A. A. Sebak, “LIMITATIONS OF PEGYLATED NANOCARRIERS: UNFAVOURABLE PHYSICOCHEMICAL PROPERTIES, BIODISTRIBUTION PATTERNS AND CELLULAR AND SUBCELLULAR FATES”, Int J App Pharm, vol. 10, no. 5, pp. 6–12, Sep. 2018.